Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
L04AA27	FINGOLIMOD ZENTIVA	G	Fingolimod Hydrochloride - 0.5mg	0.5mg	Capsule, hard	32,406,715 L.L
R03AK06	FLUDALT DUO	G	Salmeterol (xinafoate) - 50mcg, Fluticasone propionate - 500mcg		Capsule, inhalation	3,169,668 L.L
C10AB05	FENOFIBRATE ARROW	G	Fenofibrate - 160mg	160mg	Tablet	639,669 L.L
J01MA14	FLOXIMOX	G	Moxifloxacin (HCl) - 400mg	400mg	Tablet, film coated	1,062,276 L.L
C10AB05	FENOSUP LIDOSE	G	Fenofibrate - 160mg	160mg	Capsule	774,053 L.L
C10AB05	FINOFIB BENTA	G	Fenofibrate - 160mg	160mg	Tablet, film coated	788,388 L.L
M01AE51	FLUMIX BENTA	G	Ibuprofen - 200mg, Guaifenesin - 200mg, Chlorpheniramine maleate - 2mg, Phenylephrine HCl - 5mg		Tablet, film coated	875,417 L.L
J01DD02	FORTECARE	G	Ceftazidime - 1g	1g	Injectable powder for solution	10,011,695 L.L
M01AE51	FLUMIX BENTA	G	Ibuprofen - 200mg, Guaifenesin - 200mg, Chlorpheniramine maleate - 2mg, Phenylephrine HCl - 5mg		Tablet, film coated	460,746 L.L
C10AB05	FINACOR	G	Fenofibrate micronised - 160mg	160mg	Capsule	774,309 L.L
C10AB05	FENOGAL	G	Fenofibrate micronised - 200mg	200mg	Capsule, micronized	392,402 L.L
G04CB01	FINASTEKERN	G	Finasteride - 5mg	5mg	Tablet, film coated	560,382 L.L
N02BE01	FEBRADOL	G	Paracetamol - 500mg	500mg	Tablet	327,642 L.L
G04CB01	FINASTERIDE	G	Finasteride - 5mg	5mg	Tablet, film coated	356,118 L.L
G04CB01	FINASTERIDE ARROW LAB	G	Finasteride - 5mg	5mg	Tablet, film coated	516,036 L.L
G04CB01	FINASTERIDE BAILLEUL	G	Finasteride - 1mg	1mg	Tablet, film coated	1,619,330 L.L
G04CB01	FINASTERIDE BAILLEUL	G	Finasteride - 1mg	1mg	Tablet, film coated	1,619,330 L.L
R03AK07	FORACORT 200	G	Formoterol fumarate dihydrate - 4.5mcg/inhalation, Budesonide - 200mcg/inhalation		Metered dose inhaler	2,159,555 L.L
N02BE01	FEBRADOL JOINT	G	Paracetamol - 665mg	665mg	Tablet	289,246 L.L
R03AK07	FORACORT 400	G	Formoterol fumarate - 4.5mcg/inhalation, Budesonide - 400mcg/inhalation		Metered dose inhaler	3,104,276 L.L
D11AX10	FINJUVE	G	Finasteride - 2.275mg/ml	2.275mg/ml	Spray, solution	6,708,462 L.L
D11AX16	FLOREXA	G	Eflornithine (HCl) - 11.5%	11.50%	Cream	3,527,587 L.L
S01AE01	FLOXIGEN	G	Ofloxacin - 3mg/ml	3mg/ml	Drops solution	358,806 L.L
N05AB02	FLUPHENAZINE HCl	G	Fluphenazine (HCl) - 5mg	5mg	Tablet, scored	624,567 L.L
S01AE01	FLOXEDOL	G	Ofloxacin - 3mg/ml	3mg/ml	Gel	339,992 L.L
S01AE07	FORTYMOX	G	Moxifloxacin (HCl) - 0.5%	0.50%	Drops solution	772,709 L.L
J01XX01	FOSFOKEY	G	Fosfomycine (trométamol) - 3g	3g	Granules for solution	399,121 L.L
J01XX01	FOSFOLAG	G	Fosfomycine (trométamol) - 3g	3g	Granules for solution	399,121 L.L
L01BB05	FLUDARABIN EBEWE	G	Fludarabine Dihydrogenophosphate - 50mg/2ml	50mg/2ml	Injectable solution	3,567,902 L.L
L01BB05	FLUDARABINE PHOSPHATE NEAPOLIS	G	Fludarabine Dihydrogenophosphate - 50mg/2ml	50mg/2ml	Injectable solution	4,031,528 L.L